Ransomware Tracker by ExposureDrift
Dashboard / Victims / Crystal Pharmatech

Crystal Pharmatech was listed on 21 August 2026 by the Eclipse ransomware group (the group's claim; Ransomware Tracker by ExposureDrift has not confirmed a breach). Eclipse listed 4 organizations that month and 23 in total.

  • Listed 89 days ago.
  • 1198 organizations were listed by all groups in August 2026, see the month.
  • 135 in Healthcare that month.
  • 411 in US that month.
  • 1 other listing for the same organization.

Updated 2026-11-18 07:20 UTC. Data: public leak-site listings. How we work.

Crystal Pharmatech corporate emblem
Listed by Eclipse Disclosed: 2026-08-23 06:35 UTC

Crystal Pharmatech

crystalpharmatech.com Healthcare US

Named in 2 separate listings

Another listing name this organization: a different group, or the same group months apart. Each is a claim the group published, not a confirmed breach. The same group listing it again within a few months is not counted: that is the same listing sent twice or moved from countdown to published.

This listing: Eclipse, 23 Aug 2026 qilin, 06 Aug 2026

Threat Group Post & Evidence

Listed by
Eclipse 23 listings in total

The listing states no data size and no ransom demand.

No capture of the original post

We only show a screenshot when we captured the group's own page ourselves. For this listing we have not, so none is shown.

The group's leak-site address is on paid plans

Free accounts see who listed this organization, when, and what the post claims. The address of the group's own page is shown to license-key holders. If you have a key, see what a license key adds.

What the group says it holds

Taken from the group's own post. Ransomware Tracker by ExposureDrift has not seen the data and cannot confirm any of this.

Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. Established in 2010 and have R&D centers located in Suzhou (China), New Jersey, San Francisco (USA), and Toronto (Canada). Also its key differentiator is integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development and manufacturing, clinical supply.

What to do about this listing

Choose who you are. Each step shows why it appears and, where we have one, its source. General guidance, not legal or incident-response advice.

If you work with Crystal Pharmatech (customer, supplier or partner)

Within 3 days

  • Do not open the group's page or download the data Do not visit the leak site or download files from a listing. Holding stolen data can be unlawful, and the files can carry malware. Wait for the company's own notice. Why: A safety rule for any leak listing.
  • Ask Crystal Pharmatech directly Write to your contact and ask whether your data, or your access to their systems, is in scope, and ask for a written statement. Your contract or data-protection law may oblige them to tell you if your data is affected: check the notification clause. Why: A listing is only the group's claim; the company is the one who can confirm what was taken.
  • Review what Crystal Pharmatech can reach of yours List the accounts, API keys, VPN or SSO connections and shared mailboxes this company has with you. Rotate the keys you gave them and remove access they do not need. Why: Access a supplier holds is how a listing about them can become a problem for you.

Within 30 days

  • Keep watching Crystal Pharmatech A supplier's listing can change after the first sighting: the group can add data, change the status or publish. Add the company to your supplier list to be told, and check your own domain too. Why: A listing is a moving claim, not a single event. Add to your supplier list Check your own domain
If you are Crystal Pharmatech

Within 3 days

  • Find out what was actually taken The post names no specific kind of data, so no data-specific steps are shown. Check the group's own post and your logs to learn what is claimed and what is real. Why: The listing text names no data types.
  • Check regulatory and stakeholder notification duties United States: state breach-notification laws apply; listed companies may also have SEC Form 8-K Item 1.05 duties for material incidents, and HIPAA applies to health data. Health data adds sector rules. This is general guidance, not legal advice: confirm current rules with counsel. Why: Listing country: United States.

Within 30 days

  • Check shared suppliers and software List the suppliers and software you share with other Healthcare organizations and ask them whether they were affected. Why: Eclipse listed 1 other Healthcare organization(s) in the last 90 days.
General readiness for any ransomware claim (not about this listing)
  • Offline, immutable backups and a restore drill Keep backups outside domain-admin reach and practise a restore; a leak does not remove the risk of re-encryption. Why: General practice for any ransomware claim; not specific to this listing.
  • Look for mass file access and unusual outbound transfers Review EDR, proxy and identity logs for bulk reads, archive creation and large uploads to file-sharing services. Why: General practice for any ransomware claim; not specific to this listing.
  • Phishing-resistant MFA on remote access Enforce MFA on VPN, SSO and admin panels, and retire password-only or SMS-based remote access. Why: General practice for any ransomware claim; not specific to this listing.

Listing details

Resolved Domain crystalpharmatech.com
Industry Vertical Healthcare
Country US
Enrichment Status ENRICHED

Listing severity score (heuristic)

62/100 • ELEVATED

A heuristic built from sector, group, data volume and claim details. It is not evidence that a breach occurred or a measure of harm.

1. Sector Criticality 30/30 pts
Healthcare and life sciences
2. Group tier 10/25 pts
Tier 3: all other groups
3. Data Volume & PII Scope 10/25 pts
Baseline: no size or sensitive data named in the post
Formula: sector • group tier • data claimed (scaled to 100) Rule-based score

External Attack Surface Profile

ASM Intelligence
65/100 • HIGH
Last Audited: 2026-11-14 16:14 UTC Passive Recon
Total Network Assets 2
1 hosts • 1 unique IPs
0 cloud-hosted • 4 SaaS
Subdomain Assets 1
Critical Panels 0 (VPN/Admin/SSO)
Non-Prod / UAT 0 Staging/Dev
SaaS Ecosystem 4 Cloud Apps
Primary CSP Alibaba Cloud -
Email Security Grade B (SPF/DMARC)
Open the full attack surface scan →
Is Your Organization Exposed?

Run a free passive scan on your own domain to see what an attacker can see from the outside.

Defense Telemetry

Passive DNS
Mail Gateway Not Disclosed / Unresolved
DNS Authority Standard Authoritative
Edge CDN / Shield None
SPF Record Missing
DMARC Policy Missing
Public DNS records only • no port scanning

More Claims by Eclipse

All →
La'ala Al Kuwait Real Estate Co KSCC
Retail & E-Commerce 2026-11-09 18:52 UTC
globalair.com.sg
Transportation 2026-11-08 16:22 UTC
Comercial en Fletes México, S.A. de C.V.
Transportation 2026-11-06 20:21 UTC
PART2 Global AirFreight International
Transportation 2026-10-17 22:21 UTC
Taiwan Otsuka Pharmaceutical
Healthcare 2026-10-14 17:51 UTC
japantimes.co.jp
Technology 2026-10-14 17:51 UTC

Other listings for this name

2 listings
Eclipse Viewing Now
2026-08-23 06:35 UTC Severity: 62/100
qilin CRITICAL
2026-08-06 23:28 UTC Open listing →